# The Movement of Botulinum Toxin Through the Lateral Gastrocnemius Muscle in Humans: An Expanded Examination

> **NCT03367429** · PHASE4 · TERMINATED · sponsor: **Weill Medical College of Cornell University** · enrollment: 4 (actual)

## Conditions studied

- Stroke
- Muscle Spasticity

## Interventions

- **DRUG:** Botox

## Key facts

- **NCT ID:** NCT03367429
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-06-15
- **Primary completion:** 2019-09-18
- **Final completion:** 2019-09-18
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** too difficult to recruit subjects for the study - muscles naive to botulinum toxin were required and seems that wide availability of the toxin has severely depleted potential subjects.
- **Last updated:** 2021-12-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03367429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03367429, "The Movement of Botulinum Toxin Through the Lateral Gastrocnemius Muscle in Humans: An Expanded Examination". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03367429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*